San Diego-based Biocept Inc. has been on a roll this year to carve out a spot for itself in the emerging field of liquid biopsy and personalized medicine. A $10 million offering of common stock and warrants is the company's latest move to support its expanding menu of available companion tests for immuno-oncology therapeutics.

A single-port laparoscopic device designed to knock down a key barrier in the space has earned a financial boost just days ahead of the product's official U.S. launch.

Growing up really is hard to do – especially for a small med-tech company in a big pond – but ICU Medical Inc. has "finally delivered" in a transformative way, according to analysts reacting to ICU's $1 billion deal to acquire Pfizer Corp.'s infusion therapy business, Hospira Infusion Systems. "Small companies either have to get bigger or get consolidated, and it's incredibly hard for small companies to get bigger in maturing markets," ICU CEO Vivek Jain said during a conference call Thursday. The acquisition will create a pure-play infusion therapy company with combined revenue...

Growing up really is hard to do – especially for a small med-tech company in a big pond – but ICU Medical Inc. has "finally delivered" in a transformative way, according to analysts reacting to ICU's $1 billion deal to acquire Pfizer Corp.'s infusion therapy business, Hospira Infusion Systems.

Transenterix Inc.'s Senhance recently scrubbed in, so to speak, to lend its robotic hands to a gynecologic surgeon in Italy during a major cervical cancer procedure. It was the first time the company's recently re-branded surgical robotic system has been used during a radical hysterectomy and, if the surgeon's feedback is any indication, it probably won't be the last time the Senhance is involved with a complex gynecologic oncology case. A radical hysterectomy involves an extensive pelvic lymph node dissection and removal of the patient's uterus and parametrium, ovaries, fallopian tubes, and part of...

Transenterix Inc.'s Senhance recently scrubbed in, so to speak, to lend its robotic hands to a gynecologic surgeon in Italy during a major cervical cancer procedure. It was the first time the company's recently re-branded surgical robotic system has been used during a radical hysterectomy and, if the surgeon's feedback is any indication, it probably won't be the last time the Senhance is involved with a complex gynecologic oncology case.

Johnson & Johnson's diabetes unit warned patients this week that the Animas Onetouch Ping insulin pumps may be vulnerable to a cyberattack, but the probability of one of the devices actually being hacked is "extremely low," the company said. The pump could potentially be accessed through its unencrypted radio frequency communication system, but such an attack would require technical expertise, sophisticated equipment and proximity to the device, according to a letter the West Chester, Pa.-based Animas Corp. sent to patients on Monday. The company noted that the Onetouch Ping system is not connected to...

Johnson & Johnson's diabetes unit warned patients this week that the Animas Onetouch Ping insulin pumps may be vulnerable to a cyberattack, but the probability of one of the devices actually being hacked is "extremely low," the company said.